Transforming growth factor β1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans

Infection and Immunity

Volumn 68, Issue 9, 2000, Pages 5405-5407

  Robinson, P ^a   Okhuysen, P C ^a   Chappell, C L ^a   Lewis, D E ^a   Shahab, I ^a   Lahoti, S ^a   White A C , Jr ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CRYPTOSPORIDIUM PARVUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; INTESTINE BIOPSY; JEJUNUM MUCOSA; OOCYST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTOZOAL INFECTION; RECEPTOR DOWN REGULATION; RNA PROBE; WOUND HEALING;

ANIMALS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; HUMANS; JEJUNUM; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033863459     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.9.5405-5407.2000     Document Type: Article

References (28)

1. Growth factors in inflammatory bowel disease
2. Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G
3. Mucosal immunity and inflammatory. II. The yin and yang of T cells in intestinal inflammation: Pathogenic and protective roles in a mouse colitis model
4. Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor beta
5. The infectivity of Cryptosporidium parvum in healthy volunteers
6. Intensity of infection in AIDS-associated cryptosporidiosis
7. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis
8. Regulatory T cells and inflammatory bowel disease
9. Gastrointestinal mucosal regeneration: Role of growth factors
10. TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii
11. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii
12. TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice
13. Effector and regulatory lymphoid cells and cytokines in mucosal sites
14. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii
15. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum
16. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults
17. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum
18. Transforming growth factor-betal preserves epithelial barrier function: Identification of receptors, biochemical intermediates, and cytokine antagonists
19. Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine
20. Healing the epithelium: Solving the problem from two sides
21. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells
22. Granuloma cytokines in murine cysticercosis
23. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
24. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation
25. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease
26. Interferon gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion
27. Site-specific changes in transforming growth factor-alpha and -beta1 expression in colonic mucosa of adolescents with inflammatory bowel disease
28. Cell-mediated immunity to Toxoplasma gondii: Initiation, regulation and effector function